CCL2 and breast cancer: Heiskala et al. compared the levels of CCL2 and markers expressed by monocytes/macrophages (CD163, CD14, and the CCL2 receptor CCR2) in samples from CNBs to those from the corresponding resected tumors from 52 patients with primary BC.